TipRanks
Go Ultimate55% OFF

Iovance Biotherapeutics (0JDK) Cash flow

Iovance Biotherapeutics Cash Flow

GB:0JDK's free cash flow for Q2 2026 was $-66.28M. For the 2026 fiscal year, GB:0JDK's free cash flow was decreased by $-5.44M and operating cash flow was $-60.84M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -302.41M$ -352.98M$ -361.82M$ -292.76M$ -227.94M
$ 47.50M$ -96.41M$ -155.24M$ 256.45M$ 132.00K
$ 300.77M$ 390.66M$ 462.96M$ 190.15M$ 239.27M
$ 169.06M$ 122.05M$ 181.32M$ 238.16M$ 84.31M
$ -336.24M$ -364.05M$ -384.11M$ -313.18M$ -265.51M

Currency in USD

Iovance Biotherapeutics Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing